Wuhan Yzy Biopharma Announces Extraordinary General Meeting

• Wuhan YZY Biopharma will hold an extraordinary general meeting in Wuhan, Hubei province, China, on November 17, 2026.
• Shareholders will consider issuing 35,592,400 new Domestic Shares to three founder-directors at RMB 2.43 each, raising approximately RMB 86.49 million.
• Other proposals cover a specific mandate for the issuance, a whitewash waiver exempting subscribers from a mandatory general offer, and related articles amendments.
• Approximately 90% of estimated net proceeds of RMB 83 million would repay bank borrowings; the remainder would fund working capital.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wuhan Yzy Biopharma Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261030-12390878), on October 30, 2026, and is solely responsible for the information contained therein.